NCT04464187View on ClinicalTrials.gov

A Study to Evaluate Pregnancy Outcomes in Females Treated With Oral Elagolix Tablets and Capsules

TerminatedOBSERVATIONAL
Enrollment

173

Participants

Timeline

Start Date

January 6, 2022

Primary Completion Date

July 11, 2025

Study Completion Date

July 11, 2025

Conditions
EndometriosisUterine Fibrioids
Trial Locations (1)

27703-8426

Iqvia /Id# 240918, Durham

Sponsors

Lead Sponsor

AbbVie
All Listed Sponsors
lead

AbbVie

INDUSTRY